ANLON HEALTHCARE LIMITED
AHCL · General/Diversified · NSE
₹15
Current Market Price
Fair Value (DCF)
₹10
Discount to FV
-31.6%
Updated just now
YieldIQ Score
50/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
26%
ROE
25.5%
Debt/Equity
0.83
WACC
11.1%
Market Cap
₹804.71 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
20.9%
Return on capital employed
EV / EBITDA
13.1×
Enterprise multiple
Debt / EBITDA
0.9×
Leverage vs earnings
Interest Coverage
8.1×
EBIT covers interest
Current Ratio
2.64×
Short-term liquidity
Asset Turnover
0.95×
Revenue per ₹ of assets
Revenue CAGR (3Y)
15.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹15.14
Bear case
Discount -176.3%
Base case
Discount -46.3%
Bull case
Discount -21.9%
Ratio Trends
AHCL · last 4 annual periods
ROE
25.5%
ROCE
20.9%
Operating Margin
—
Debt / Equity
0.83×
PE
—
EV / EBITDA
—
Historical Financials
AHCL · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 yfinance | 2025 yfinance | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹57.1 Cr | ₹113 Cr | ₹66.6 Cr | ₹120 Cr | +28.2% |
| EBITDA | ₹5.8 Cr | ₹12.6 Cr | ₹15.7 Cr | ₹32.4 Cr | +77.1% |
| EBIT | ₹4.0 Cr | ₹10.8 Cr | ₹13.8 Cr | ₹30.7 Cr | +97.2% |
| PAT | ₹-0.1 Cr | ₹5.8 Cr | ₹9.7 Cr | ₹20.5 Cr | — |
| EPS (diluted) | ₹-0.02 | ₹1.09 | ₹1.82 | ₹3.86 | — |
| CFO | ₹-1.8 Cr | ₹-2.8 Cr | ₹-3.2 Cr | ₹-22.6 Cr | — |
| CapEx | ₹-0.5 Cr | ₹-0.4 Cr | ₹-3.5 Cr | ₹-0.5 Cr | — |
| FCF | ₹-2.2 Cr | ₹-3.2 Cr | ₹-6.8 Cr | ₹-23.1 Cr | — |
| Total Assets | ₹85.0 Cr | ₹112 Cr | ₹128 Cr | ₹181 Cr | +28.7% |
| Total Debt | ₹62.4 Cr | ₹70.3 Cr | ₹81.2 Cr | ₹66.6 Cr | +2.2% |
| Shareholders' Equity | ₹1.6 Cr | ₹7.4 Cr | ₹21.0 Cr | ₹80.4 Cr | +272.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
AHCL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
ANUHPHR ANUHPHR | — | — | Pending | 11.7% | — |
SIGACHI SIGACHI | — | — | Pending | 11.3% | — |
 KILITCH KILITCH | — | — | Pending | 10.8% | — |
ZIMLAB ZIMLAB | — | — | Pending | 4.8% | — |
AMANTA AMANTA | — | — | Pending | 6.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for AHCL in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. ANLON HEALTHCARE LIMITED (AHCL.NS) trades at 15.14 vs a model fair value of 10.35, a gap of -31.6%. Piotroski F-score: 6/9. Moat label: W...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of AHCL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for AHCL →
Compare
Head-to-head with peers
Compare AHCL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse AHCLNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.